Free shipping on all orders over $ 500

Prasugrel hydrochloride

Cat. No. M1895

All AbMole products are for research use only, cannot be used for human consumption.

Prasugrel hydrochloride Structure
Size Price Availability Quantity
25mg USD 30  USD30 In stock
50mg USD 45  USD45 In stock
100mg USD 60  USD60 In stock
250mg USD 110  USD110 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Prasugrel hydrochloride is a novel antiplatelet agent that is a third-generation thienopyridine. Prasugrel produces inhibition of platelet aggregation to 20 μM or 5 μM ADP. Prasugrel hydrochloride binds to P2Y12 receptors and showed greater platelet inhibition and decreased incidence of ischemic events when compared to clopidogrel. In the absence of lansoprazole, the extent of absorption (AUC) of prasugrel free base was about 8-9% lower, while the rate of absorption (Cmax) after administration of prasugrel free base was 20% lower when compared to prasugrel hydrochloride. When lansoprazole was used to raise the pH level in the upper gastro-intestinal tract, AUC was decreased by 25% after administration of prasugrel hydrochloride and by 41% after prasugrel free base. In addition, the peak plasma levels were decreased by 52% and 72%, respectively (geometric means). The relative bioavailability of the prasugrel free base compared to prasugrel hydrochloride, both in the presence and in the absence of the proton pump inhibitor lansoprazole, differs so much that most probably a generic formulation containing prasugrel free base will not be equivalent in all aspects to the originator product.

Chemical Information
Molecular Weight 409.91
Formula C20H20FNO3S.HCl
CAS Number 389574-19-0
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Seiler D, et al. Arzneimittelforschung. Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor.

Related P2 Receptor Products
NF449 

NF449 is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

NF279 

NF279 is a potent selective and reversible P2X1 receptor antagonist, with an IC50 of 19 nM.

NF110 

NF110 is a P2X3 receptor antagonist (Ki = 36 nM) and inactive toward P2Y receptors stably expressed (IC50s > 10 M).

PSB-12062

PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

NF449 octasodium 

NF449 octasodium is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Prasugrel hydrochloride supplier, P2 Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.